Although a company like Ramsay Health Care Limited (ASX: RHC) seems to have been a blue chip share forever, it is worth remembering that it was a small cap at one point.
The private hospital operator hit the ASX boards back in September 1997 and has gone onto become one of the largest companies on the local market.
Given that its shares were trading at $1.15 shortly after listing and are now fetching $66.99, early investors have done incredibly well. I believe this demonstrates why having a little exposure to the small side of the market can be a very good thing for a portfolio.
With that in mind, here are three small cap ASX shares I think have a lot of potential:
Bigtincan Holdings Ltd (ASX: BTH)
Bigtincan is a fast-growing provider of enterprise mobility software. Its Bigtincan Hub’s AI-driven real-time automation enhances the customer experience, and gives sales and marketing teams the tools they need to deliver stronger results. Demand for its software has been growing strongly in recent years and this has continued to be the case during the pandemic. As a result, the company expects to deliver on its 30% to 40% organic revenue growth target in FY 2020.
Mach7 Technologies Ltd (ASX: M7T)
Mach7 is a medical imaging data management solutions provider. Its software helps inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. It has been a positive performer in FY 2020 and expects to report revenue of at least $18 million and its first positive EBITDA result. Looking ahead, its future looks very bright. Especially after its recent acquisition of leading provider of enterprise image viewing technology Client Outlook. This acquisition has increased Mach7’s total addressable market from US$0.75 billion to US$2.75 billion.
Whispir (ASX: WSP)
A final small cap to look at is Whispir. It is a software-as-a-service communications workflow platform provider. Whispir enables businesses to improve their communications and ensures that people everywhere receive timely, useful, and actionable content in a manner that reflects their individual needs and preferences. Its platform has been experiencing incredible demand during the pandemic. This appears to have positioned Whispir to deliver a very strong full year result this month. Given the quality of its offering and its large market opportunity, I expect more of the same in FY 2021 and beyond.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO, MACH7 FPO, and Whispir Ltd. The Motley Fool Australia has recommended BIGTINCAN FPO, MACH7 FPO, Ramsay Health Care Limited, and Whispir Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Where to invest your Telstra (ASX:TLS) dividends – September 24, 2020 5:00pm
- Why retirees should buy these safe and strong ASX dividend shares – September 24, 2020 4:30pm
- The NEXTDC (ASX:NXT) share price just hit a record high: Can it go higher? – September 24, 2020 4:21pm